Bio-Thera Solutions, Ltd. (SHA:688177)
China flag China · Delayed Price · Currency is CNY
26.32
+0.02 (0.08%)
At close: May 30, 2025, 2:57 PM CST
-5.05%
Market Cap 10.82B
Revenue (ttm) 788.13M
Net Income (ttm) -484.68M
Shares Out 414.08M
EPS (ttm) -1.17
PE Ratio n/a
Forward PE 93.29
Dividend n/a
Ex-Dividend Date n/a
Volume 4,471,939
Average Volume 3,126,670
Open 26.50
Previous Close 26.30
Day's Range 25.93 - 27.23
52-Week Range 17.70 - 30.38
Beta 0.42
RSI 72.22
Earnings Date Aug 22, 2025

About Bio-Thera Solutions

Bio-Thera Solutions, Ltd., a biopharmaceutical company, researches and develops novel therapeutics for the treatment of cancer, autoimmune, cardiovascular, eye diseases, and other severe unmet medical needs in China and internationally. The company offers QLETLI for treatment of ankylosing spondylitis, rheumatoid arthritis, psoriasis, Crohn’s disease, and uveitis; POBEVCY to treat patients with metastatic colorectal cancer, non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, persistent, recurrent, a... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 1,251
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688177
Full Company Profile

Financial Performance

In 2024, Bio-Thera Solutions's revenue was 743.17 million, an increase of 5.44% compared to the previous year's 704.79 million. Losses were -510.30 million, 29.3% more than in 2023.

Financial Statements

News

There is no news available yet.